In Vitro Model for Studying of the Role of IGFBP6 Gene in Breast Cancer Metastasizing
Standard
In Vitro Model for Studying of the Role of IGFBP6 Gene in Breast Cancer Metastasizing. / Nikulin, S V; Raigorodskaya, M P; Poloznikov, A A; Zakharova, G S; Schumacher, U; Wicklein, D; Stürken, C; Riecken, K; Fomicheva, K A; Alekseev, B Ya; Shkurnikov, M Yu.
in: B EXP BIOL MED+, Jahrgang 164, Nr. 5, 03.2018, S. 688-692.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - In Vitro Model for Studying of the Role of IGFBP6 Gene in Breast Cancer Metastasizing
AU - Nikulin, S V
AU - Raigorodskaya, M P
AU - Poloznikov, A A
AU - Zakharova, G S
AU - Schumacher, U
AU - Wicklein, D
AU - Stürken, C
AU - Riecken, K
AU - Fomicheva, K A
AU - Alekseev, B Ya
AU - Shkurnikov, M Yu
PY - 2018/3
Y1 - 2018/3
N2 - IGFBP6 gene plays an important role in the pathogenesis of breast cancer. In this work, we performed knockdown of IGFBP6 gene in MDA-MB-231 cells and obtained a stable cell line. Knockdown of IGFBP6 gene was confirmed by the real-time PCR. The influence of IGFBP6 gene on migration and proliferation of breast cancer cells was studied. Knockdown of IGFBP6 gene reduced migration activity of MDA-MB-231 cells and increased their proliferation rate. This in vitro cell model can be used for the further analysis of the role of IGFBP6 gene in the pathogenesis of breast cancer.
AB - IGFBP6 gene plays an important role in the pathogenesis of breast cancer. In this work, we performed knockdown of IGFBP6 gene in MDA-MB-231 cells and obtained a stable cell line. Knockdown of IGFBP6 gene was confirmed by the real-time PCR. The influence of IGFBP6 gene on migration and proliferation of breast cancer cells was studied. Knockdown of IGFBP6 gene reduced migration activity of MDA-MB-231 cells and increased their proliferation rate. This in vitro cell model can be used for the further analysis of the role of IGFBP6 gene in the pathogenesis of breast cancer.
KW - Journal Article
U2 - 10.1007/s10517-018-4060-7
DO - 10.1007/s10517-018-4060-7
M3 - SCORING: Journal article
C2 - 29582205
VL - 164
SP - 688
EP - 692
JO - B EXP BIOL MED+
JF - B EXP BIOL MED+
SN - 0007-4888
IS - 5
ER -